| Product NDC: | 43063-196 |
| Proprietary Name: | Lithium Carbonate |
| Non Proprietary Name: | Lithium Carbonate |
| Active Ingredient(s): | 300 mg/1 & nbsp; Lithium Carbonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43063-196 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076243 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030301 |
| Package NDC: | 43063-196-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE, PLASTIC (43063-196-60) |
| NDC Code | 43063-196-60 |
| Proprietary Name | Lithium Carbonate |
| Package Description | 60 CAPSULE in 1 BOTTLE, PLASTIC (43063-196-60) |
| Product NDC | 43063-196 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lithium Carbonate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20030301 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | LITHIUM CARBONATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Mood Stabilizer [EPC] |